Qiang Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Qiang Li has a total of 82 co-authors. Here are the top co-authors by number of shared publications:
Xiaole Zhu
Pancreas Center
13 shared publicationsChaoqun Hou
Pancreas Center
11 shared publicationsYunpeng Peng
Pancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China
11 shared publicationsChenyuan Shi
Pancreas Center, First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing 210029, Jiangsu Province, China; Pancreas Institute, Nanjing Medical University, Nanjing 210029, Jiangsu Province, China
10 shared publications- Yi Miao
Pancreas Center, Nanjing BenQ Medical Center, The Affiliated BenQ Hospital of Nanjing Medical University, Nanjing, China
10 shared publications Dongya Huang
Pancreas Center
6 shared publications
Latest Publications
- 4 April 2026
- Published by Elsevier in Pancreatology
- Vol. 26 (4) , 573-580
Serum GAS6 is useful biomarker for identifying patients with severe acute pancreatitis within 24 h of admission: a multi-cohort analysis of 869 patients
- 4 April 2026
- Published by Elsevier in Pancreatology
- Vol. 26 (4) , 573-580
Serum GAS6 is useful biomarker for identifying patients with severe acute pancreatitis within 24 h of admission: a multi-cohort analysis of 869 patients
- 28 October 2025
- Published by Elsevier in Seminars in Oncology
- Vol. 53 (1) , 152428
Machine learning-based integration develops a lactate metabolism related gene signature for improving outcomes in pancreatic ductal adenocarcinoma
- 28 October 2025
- Published by Elsevier in Seminars in Oncology
- Vol. 53 (1) , 152428
Machine learning-based integration develops a lactate metabolism related gene signature for improving outcomes in pancreatic ductal adenocarcinoma
- 5 February 2025
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 751, 151451
Multi-omics profiles reveal immune microenvironment alterations associated with PD-L1 checkpoint in acute pancreatitis in the early phase
- 5 February 2025
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 751, 151451
Multi-omics profiles reveal immune microenvironment alterations associated with PD-L1 checkpoint in acute pancreatitis in the early phase
- Open Access
- 23 December 2024
- Published by Springer Nature in BMC Public Health
- Vol. 24 (1) , 1-11
The U-shaped correlation between serum VD concentration and systemic immune-inflammatory index: results from the NHANES database prospective cohort study
Vitamin D (VD) plays a critical role in regulating systemic inflammation, but its correlation with the systemic immune-inflammatory index (SII) remains unclear. This study aimed to explore the relationship between serum VD concentration, dietary VD intake, and SII using data from the National Health and Nutrition Examination Survey (NHANES). Data from NHANES 2007–2018 and NHANES 2007–2020 were analyzed for serum VD levels and dietary VD intake, respectively. Restricted cubic splines (RCS) and logistic regression were used to assess associations between VD and SII. Mediation analysis was conducted to evaluate the role of SII in VD-related disease outcomes and mortality. Serum VD concentration exhibited a U-shaped correlation with SII (P-overall = 0.005; P-non-linear = 0.002). Severe VD deficiency significantly elevated SII levels compared to insufficiency or sufficiency groups. No association was observed between dietary VD intake and SII. Mediation analysis revealed that SII mediated the effects of VD on all-cause and cardiovascular disease-related mortality, but not on cancer, hypertension, or diabetes development. A U-shaped relationship exists between serum VD and SII, with VD supplementation potentially reducing systemic inflammation and improving cardiovascular outcomes. Future studies should explore VD’s role in systemic inflammation and its clinical implications.
- 23 December 2024
- Published by Springer Nature in BMC Public Health
- Vol. 24 (1) , 1-11
Open AccessThe U-shaped correlation between serum VD concentration and systemic immune-inflammatory index: results from the NHANES database prospective cohort study
Vitamin D (VD) plays a critical role in regulating systemic inflammation, but its correlation with the systemic immune-inflammatory index (SII) remains unclear. This study aimed to explore the relationship between serum VD concentration, dietary VD intake, and SII using data from the National Health and Nutrition Examination Survey (NHANES). Data from NHANES 2007–2018 and NHANES 2007–2020 were analyzed for serum VD levels and dietary VD intake, respectively. Restricted cubic splines (RCS) and logistic regression were used to assess associations between VD and SII. Mediation analysis was conducted to evaluate the role of SII in VD-related disease outcomes and mortality. Serum VD concentration exhibited a U-shaped correlation with SII (P-overall = 0.005; P-non-linear = 0.002). Severe VD deficiency significantly elevated SII levels compared to insufficiency or sufficiency groups. No association was observed between dietary VD intake and SII. Mediation analysis revealed that SII mediated the effects of VD on all-cause and cardiovascular disease-related mortality, but not on cancer, hypertension, or diabetes development. A U-shaped relationship exists between serum VD and SII, with VD supplementation potentially reducing systemic inflammation and improving cardiovascular outcomes. Future studies should explore VD’s role in systemic inflammation and its clinical implications.
- Open Access
- 2 December 2023
- Published by Springer Nature in Antimicrobial Resistance & Infection Control
- Vol. 12 (1) , 1-12
Antibiotic prophylaxis after 48 h postoperatively are not associated with decreased surgical site infections and other healthcare associated infections in pancreatic surgery patients: a retrospective cohort study
It is controversial whether antibiotic should be used prophylactically 48 h after pancreatic surgery. Hence, the association of antibiotic prophylaxis (AP) after 48 h postoperatively with the incidence of surgical site infections (SSIs) and other healthcare-associated infections (HAIs) in patients receiving pancreatic surgery was evaluated. A retrospective cohort analysis was performed on 1073 patients who underwent pancreatic surgery. These patients were categorized into the non-AP after 48 h postoperatively group (n = 963) and the AP after 48 h postoperatively group (n = 110) based on whether or not they obtained AP from 48 h to 30 days after surgery. Outcomes included SSIs and other HAIs. The incidence of SSIs in the non-AP after 48 h postoperatively group (98/963, 10.2%) was notably lower than that in the AP after 48 h postoperatively group (22/110, 20.0%) (P = 0.002). Other HAIs incidence was not significantly different between the non-AP after 48 h postoperatively group (77/963, 8.0%) and the AP after 48 h postoperatively group (11/110, 10.0%) (P = 0.468). Multiple regression analysis demonstrated that AP after 48 h postoperatively was a risk factor for SSIs (OR = 2.14, 95% CI 1.28–3.59) but not for other HAIs (OR = 1.24, 95% CI 0.63–2.42) after adjustment for age, gender, and diabetes. Subsequent to adjustment for all confounding factors, AP after 48 h postoperatively was not a influence factor for SSIs (OR = 2.13, 95% CI 0.76–5.99) and other HAIs (OR = 3.69, 95% CI 0.99–13.81). AP after 48 h postoperatively following pancreatic surgery was not associated with the lower morbidity rate of SSIs and other HAIs. Nonetheless, this study may facilitate further development of strategies towards standardization of the duration of AP management of pancreatic surgery.
- 2 December 2023
- Published by Springer Nature in Antimicrobial Resistance & Infection Control
- Vol. 12 (1) , 1-12
Open AccessAntibiotic prophylaxis after 48 h postoperatively are not associated with decreased surgical site infections and other healthcare associated infections in pancreatic surgery patients: a retrospective cohort study
It is controversial whether antibiotic should be used prophylactically 48 h after pancreatic surgery. Hence, the association of antibiotic prophylaxis (AP) after 48 h postoperatively with the incidence of surgical site infections (SSIs) and other healthcare-associated infections (HAIs) in patients receiving pancreatic surgery was evaluated. A retrospective cohort analysis was performed on 1073 patients who underwent pancreatic surgery. These patients were categorized into the non-AP after 48 h postoperatively group (n = 963) and the AP after 48 h postoperatively group (n = 110) based on whether or not they obtained AP from 48 h to 30 days after surgery. Outcomes included SSIs and other HAIs. The incidence of SSIs in the non-AP after 48 h postoperatively group (98/963, 10.2%) was notably lower than that in the AP after 48 h postoperatively group (22/110, 20.0%) (P = 0.002). Other HAIs incidence was not significantly different between the non-AP after 48 h postoperatively group (77/963, 8.0%) and the AP after 48 h postoperatively group (11/110, 10.0%) (P = 0.468). Multiple regression analysis demonstrated that AP after 48 h postoperatively was a risk factor for SSIs (OR = 2.14, 95% CI 1.28–3.59) but not for other HAIs (OR = 1.24, 95% CI 0.63–2.42) after adjustment for age, gender, and diabetes. Subsequent to adjustment for all confounding factors, AP after 48 h postoperatively was not a influence factor for SSIs (OR = 2.13, 95% CI 0.76–5.99) and other HAIs (OR = 3.69, 95% CI 0.99–13.81). AP after 48 h postoperatively following pancreatic surgery was not associated with the lower morbidity rate of SSIs and other HAIs. Nonetheless, this study may facilitate further development of strategies towards standardization of the duration of AP management of pancreatic surgery.
- Open Access
- 11 August 2023
- Published by Springer Nature in Research Square
Antibiotic prophylaxis after 48 hours postoperatively are not associated with decreased surgical site infections and other healthcare associated infections in pancreatic surgery patients: a retrospective cohort study
Background It is controversial whether antibiotic should be used prophylactically 48 hours after pancreatic surgery. Hence, We evaluated the association of antibiotic prophylaxis (AP) after 48 hours postoperatively with the incidence of surgical site infections (SSIs) and other healthcare-associated infections (HAIs) in patients receiving pancreatic surgery. Methods A retrospective cohort analysis was performed on 1073 patients who underwent pancreatic surgery. These patients were categorized into non-postoperative AP group (963) and postoperative AP group (110) based on whether or not they obtained AP from 48 hours to 30 days after surgery. Outcomes included SSIs and other HAIs. Results The incidence of SSIs was lower in the non-postoperative AP group (98/963, 10.2%) than in the postoperative AP group (22/110, 20.0%) (P = 0.002). Other HAIs incidence was not significantly different between the non-postoperative AP group (77/963, 8.0%) and the postoperative AP group (11/110, 10.0%) (P = 0.468). Multiple regression analysis demonstrated that postoperative AP was a risk factor for SSIs (OR = 2.14, 95%CI = 1.28–3.59) but not with other HAIs (OR = 1.24, 95%CI = 0.63–2.42) after adjustment for age, gender and diabetes. Subsequent to adjustment for all confounding factors, postoperative AP was not a risk factor for SSIs (OR = 2.42, 95%CI = 0.79–7.37) and other HAIs (OR = 4.10, 95%CI = 0.98–17.22). Conclusions Postoperative AP following pancreatic surgery was not associated with the lower morbidity rate of SSIs and other HAIs. Nonetheless, this study may facilitate further development of strategies towards standardization of the duration of AP management of pancreatic surgery.
- 11 August 2023
- Published by Springer Nature in Research Square
Open AccessAntibiotic prophylaxis after 48 hours postoperatively are not associated with decreased surgical site infections and other healthcare associated infections in pancreatic surgery patients: a retrospective cohort study
Background It is controversial whether antibiotic should be used prophylactically 48 hours after pancreatic surgery. Hence, We evaluated the association of antibiotic prophylaxis (AP) after 48 hours postoperatively with the incidence of surgical site infections (SSIs) and other healthcare-associated infections (HAIs) in patients receiving pancreatic surgery. Methods A retrospective cohort analysis was performed on 1073 patients who underwent pancreatic surgery. These patients were categorized into non-postoperative AP group (963) and postoperative AP group (110) based on whether or not they obtained AP from 48 hours to 30 days after surgery. Outcomes included SSIs and other HAIs. Results The incidence of SSIs was lower in the non-postoperative AP group (98/963, 10.2%) than in the postoperative AP group (22/110, 20.0%) (P = 0.002). Other HAIs incidence was not significantly different between the non-postoperative AP group (77/963, 8.0%) and the postoperative AP group (11/110, 10.0%) (P = 0.468). Multiple regression analysis demonstrated that postoperative AP was a risk factor for SSIs (OR = 2.14, 95%CI = 1.28–3.59) but not with other HAIs (OR = 1.24, 95%CI = 0.63–2.42) after adjustment for age, gender and diabetes. Subsequent to adjustment for all confounding factors, postoperative AP was not a risk factor for SSIs (OR = 2.42, 95%CI = 0.79–7.37) and other HAIs (OR = 4.10, 95%CI = 0.98–17.22). Conclusions Postoperative AP following pancreatic surgery was not associated with the lower morbidity rate of SSIs and other HAIs. Nonetheless, this study may facilitate further development of strategies towards standardization of the duration of AP management of pancreatic surgery.
- Open Access
- 15 June 2023
- Published by Springer Nature in BMC Cancer
- Vol. 23 (1) , 1-10
Establishment and validation of a nomogram based on coagulation parameters to predict the prognosis of pancreatic cancer
Background: In recent years, multiple coagulation and fibrinolysis (CF) indexes have been reported to be significantly related to the progression and prognosis of some cancers. Objective: The purpose of this study was to comprehensively analyze the value of CF parameters in prognosis prediction of pancreatic cancer (PC). Methods: The preoperative coagulation related data, clinicopathological information, and survival data of patients with pancreatic tumor were collected retrospectively. Mann Whitney U test, Kaplan-Meier analysis, and Cox proportional hazards regression model were applied to analyze the differences of coagulation indexes between benign and malignant tumors, as well as the roles of these indexes in PC prognosis prediction. Results: Compared with benign tumors, the preoperative levels of some traditional coagulation and fibrinolysis (TCF) indexes (such as TT, Fibrinogen, APTT, and D-dimer) were abnormally increased or decreased in patients with pancreatic cancer, as well as Thromboelastography (TEG) parameters (such as R, K, α Angle, MA, and CI). Kaplan Meier survival analysis based on resectable PC patients showed that the overall survival (OS) of patients with elevated α angle, MA, CI, PT, D-dimer, or decreased PDW was markedly shorter than other patients; moreover, patients with lower CI or PT have longer disease-free survival. Further univariate and multivariate analysis revealed that PT, D-dimer, PDW, vascular invasion (VI), and tumor size (TS) were independent risk factors for poor prognosis of PC. According to the results of modeling group and validation group, the nomogram model based on independent risk factors could effectively predict the postoperative survival of PC patients. Conclusion: Many abnormal CF parameters were remarkably correlated with PC prognosis, including α Angle, MA, CI, PT, D-dimer, and PDW. Furthermore, only PT, D-dimer, and PDW were independent prognostic indicators for poor prognosis of PC, and the prognosis prediction model based on these indicators was an effective tool to predict the postoperative survival of PC.
- 15 June 2023
- Published by Springer Nature in BMC Cancer
- Vol. 23 (1) , 1-10
Open AccessEstablishment and validation of a nomogram based on coagulation parameters to predict the prognosis of pancreatic cancer
Background: In recent years, multiple coagulation and fibrinolysis (CF) indexes have been reported to be significantly related to the progression and prognosis of some cancers. Objective: The purpose of this study was to comprehensively analyze the value of CF parameters in prognosis prediction of pancreatic cancer (PC). Methods: The preoperative coagulation related data, clinicopathological information, and survival data of patients with pancreatic tumor were collected retrospectively. Mann Whitney U test, Kaplan-Meier analysis, and Cox proportional hazards regression model were applied to analyze the differences of coagulation indexes between benign and malignant tumors, as well as the roles of these indexes in PC prognosis prediction. Results: Compared with benign tumors, the preoperative levels of some traditional coagulation and fibrinolysis (TCF) indexes (such as TT, Fibrinogen, APTT, and D-dimer) were abnormally increased or decreased in patients with pancreatic cancer, as well as Thromboelastography (TEG) parameters (such as R, K, α Angle, MA, and CI). Kaplan Meier survival analysis based on resectable PC patients showed that the overall survival (OS) of patients with elevated α angle, MA, CI, PT, D-dimer, or decreased PDW was markedly shorter than other patients; moreover, patients with lower CI or PT have longer disease-free survival. Further univariate and multivariate analysis revealed that PT, D-dimer, PDW, vascular invasion (VI), and tumor size (TS) were independent risk factors for poor prognosis of PC. According to the results of modeling group and validation group, the nomogram model based on independent risk factors could effectively predict the postoperative survival of PC patients. Conclusion: Many abnormal CF parameters were remarkably correlated with PC prognosis, including α Angle, MA, CI, PT, D-dimer, and PDW. Furthermore, only PT, D-dimer, and PDW were independent prognostic indicators for poor prognosis of PC, and the prognosis prediction model based on these indicators was an effective tool to predict the postoperative survival of PC.
- Open Access
- 8 March 2023
- Published by Wiley in Journal of Immunology Research
- Vol. 2023, 1-21
The SIX1/LDHA Axis Promotes Lactate Accumulation and Leads to NK Cell Dysfunction in Pancreatic Cancer
Background. Pancreatic cancer (PC) is a malignant cancer with poor prognosis and high mortality rate. Sine oculis homeobox homolog 1 (SIX1) participates in the development of many cancers. However, the function of SIX1 in PC is not fully understood. Methods. SIX1 expression was determined using immunohistochemistry in PC tissues and cell lines. Glucose consumption, lactate production, and ATP assays were used to detect the function of SIX1. PC cells and NK cells were cocultured to study the effect of SIX1 overexpression in PC cells on NK cell function. Chromatin immunoprecipitation (ChIP) assays were used to study the relationship between SIX1 and lactate dehydrogenase A (LDHA). A series of in vitro and in vivo assays were further applied to elucidate the important role of the SIX1/LDHA axis in metabolism and NK cell dysfunction in PC. Results. SIX1 was significantly upregulated in PC tissue; SIX1 overexpression promoted the glycolysis capacity of PANC-1 and CFPAC-1 cells and resulted in NK cell dysfunction after the NK cells had been cultured with PC cells. LDHA inhibitor partially restored the promotion of PC caused by SIX1 overexpression. According to ChIP assays, SIX1 directly binds to the LDHA promoter region. Moreover, LDHA inhibitor and lactate transporter blocker treatment promoted the function of NK cells cocultured with PC cells. In vivo experiments yielded the same results. Conclusion. The SIX1/LDHA axis promotes lactate accumulation and leads to NK cell dysfunction in PC.
- 8 March 2023
- Published by Wiley in Journal of Immunology Research
- Vol. 2023, 1-21
Open AccessThe SIX1/LDHA Axis Promotes Lactate Accumulation and Leads to NK Cell Dysfunction in Pancreatic Cancer
Background. Pancreatic cancer (PC) is a malignant cancer with poor prognosis and high mortality rate. Sine oculis homeobox homolog 1 (SIX1) participates in the development of many cancers. However, the function of SIX1 in PC is not fully understood. Methods. SIX1 expression was determined using immunohistochemistry in PC tissues and cell lines. Glucose consumption, lactate production, and ATP assays were used to detect the function of SIX1. PC cells and NK cells were cocultured to study the effect of SIX1 overexpression in PC cells on NK cell function. Chromatin immunoprecipitation (ChIP) assays were used to study the relationship between SIX1 and lactate dehydrogenase A (LDHA). A series of in vitro and in vivo assays were further applied to elucidate the important role of the SIX1/LDHA axis in metabolism and NK cell dysfunction in PC. Results. SIX1 was significantly upregulated in PC tissue; SIX1 overexpression promoted the glycolysis capacity of PANC-1 and CFPAC-1 cells and resulted in NK cell dysfunction after the NK cells had been cultured with PC cells. LDHA inhibitor partially restored the promotion of PC caused by SIX1 overexpression. According to ChIP assays, SIX1 directly binds to the LDHA promoter region. Moreover, LDHA inhibitor and lactate transporter blocker treatment promoted the function of NK cells cocultured with PC cells. In vivo experiments yielded the same results. Conclusion. The SIX1/LDHA axis promotes lactate accumulation and leads to NK cell dysfunction in PC.
- 21 October 2022
- Published by Elsevier in Molecular Immunology
- Vol. 152, 55-66
The mechanism underlying ICAM-1 and E-selectin-mediated hypertriglyceridemic pancreatitis-associated lung injury
- 21 October 2022
- Published by Elsevier in Molecular Immunology
- Vol. 152, 55-66
The mechanism underlying ICAM-1 and E-selectin-mediated hypertriglyceridemic pancreatitis-associated lung injury
- 17 September 2022
- Published by Elsevier in Tissue and Cell
- Vol. 79, 101940
RNA sequence analysis reveals pathways and candidate genes associated with pancreatic acinar cells injury in a mouse pancreatitis model
- 17 September 2022
- Published by Elsevier in Tissue and Cell
- Vol. 79, 101940
RNA sequence analysis reveals pathways and candidate genes associated with pancreatic acinar cells injury in a mouse pancreatitis model